SPIA
GYRE icon

Steward Partners Investment Advisory’s Gyre Therapeutics GYRE Stock Holding History

Steward Partners Investment Advisory’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-133
Closed -$1K – 3408
2022
Q3 		$1K Hold
133
– – ﹤0.01% 3123
2022
Q2 		$2K Hold
133
– – ﹤0.01% 2997
2022
Q1 		$1K Hold
133
– – ﹤0.01% 3184
2021
Q4 		$1K Sell
133
-934
-88% -$16K ﹤0.01% 3091
2021
Q3 		$33K Sell
1,067
-266
-20% -$8.75K ﹤0.01% 2081
2021
Q2 		$43K Hold
1,333
– – ﹤0.01% 3650
2021
Q1 		$50.4K Buy
+1,333
New +$60.9K ﹤0.01% 1978

Other funds holding GYRE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Steward Partners Investment Advisory's GYRE Position: Q4 2022 in Review

Steward Partners Investment Advisory sold out of Gyre Therapeutics (GYRE) in Q4 2022, closing a stake of 133 shares — an estimated $1K sold.

Steward Partners Investment Advisory first reported a position in GYRE in Q1 2021 and held it in 7 quarters. The position peaked at $50.4K in Q1 2021. 34 funds tracked by Wall St. Rank hold GYRE as of Q4 2022.

  • Steward Partners Investment Advisory reported no remaining Gyre Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 133 Gyre Therapeutics shares in Q4 2022, an estimated $1K.
  • Steward Partners Investment Advisory first reported a position in Gyre Therapeutics in Q1 2021 and held it in 7 quarters.
  • Steward Partners Investment Advisory's Gyre Therapeutics position peaked at $50.4K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2022, filed 15 Feb 2023.